- IMUNON (NASDAQ:IMNN) has announced an offering to raise around $3.25M upfront, with up to an additional $6.5M of potential aggregate gross proceeds.
- The biotechnology company entered into definitive agreements for the sale of 7.22M common shares (or pre-funded warrants in lieu therof) and
